As a result ADAM10 has been implicated as a potential target of modulation in diseases ranging from Alzheimer disease to heart disease and thrombosis to inflammation and cancer (1, 6, 7). This evidence concerns the gene ADAM10 and early-onset autosomal dominant Alzheimer disease.